Post-Discharge Health Assessment in Survivors of Coronavirus Disease: A Time-Point Analysis of a Prospective Cohort Study Publisher Pubmed



Sami R¹ ; Arabi S² ; Ghasemi K³ ; Akafzadeh M⁴ ; Ebrahimi S⁵ ; Toghyani A⁶ ; Mahvari R⁷ ; Moayednia R⁸ ; Dadkhahi SA⁹ ; Sadeghi S⁶ ; Marateb HR¹⁰ ; Adibi P¹¹ ; Kavosh A⁶ ; Mansourian M^{3, 10} Show Affiliations
Source: Quality of Life Research Published:2023

Abstract

Purpose: The objective of this study was to quantitatively evaluate psychological and quality of life-related complications at three months following discharge in hospitalized coronavirus disease 2019 (COVID-19) patients during the pandemic in Iran. Methods: In this time-point analysis of prospective cohort study data, adult patients hospitalized with symptoms suggestive of COVID-19 were enrolled. Patients were stratified in analyses based on severity. The primary outcomes consisted of psychological problems and pulmonary function tests (PFTs) in the three months following discharge, with Health-related quality of life (HRQoL) as the secondary outcome. Exploratory predictors were determined for both primary and secondary outcomes. Results: 283 out of 900 (30%) eligible patients were accessible for the follow-up assessment and included in the study. The mean age was 53.65 ± 13.43 years, with 68% experiencing a severe disease course. At the time of the final follow-up, participants still reported persistent symptoms, among which fatigue, shortness of breath, and cough were the most common. Based on the regression-adjusted analysis, lower levels of forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) ratio was associated with higher levels of depression (standardized β = − 0.161 (SE = 0.042), P = 0.017) and stress levels (standardized β =− 0.110 (SE = 0.047), P = 0.015). Furthermore, higher levels of anti-SARS-CoV-2 immunoglobulin-M (IgM) were associated with significantly lower levels of depression (standardized β = − 0.139 (SE = 0.135), P = 0.031). Conclusions: There is an association between lung damage during COVID-19 and the reduction of pulmonary function for up to three months from acute infection in hospitalized patients. Varying degrees of anxiety, depression, stress, and low HRQoL frequently occur in patients with COVID-19. More severe lung damage and lower COVID-19 antibodies were associated with lower levels of psychological health. © 2023, The Author(s), under exclusive licence to Springer Nature Switzerland AG.